{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:21Z","timestamp":1788134421286,"version":"build-2803163510"},"reference-count":31,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2020,12,22]]},"abstract":"<jats:p>It is estimated that a significant percentage of individuals with spina bifida (SB) are shorter than their age-matched typical peers. Parents of children with spina bifida may ask if human growth hormone is appropriate for their child. This article discusses short stature and the use of human growth hormone among children with SB. This guideline was developed for SB Healthcare Guidelines from the 2018 Spina Bifida Association\u2019s Fourth Edition of the Guidelines for the Care of People with Spina Bifida.<\/jats:p>","DOI":"10.3233\/prm-200710","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T19:34:07Z","timestamp":1600803247000},"page":"549-555","source":"Crossref","is-referenced-by-count":5,"title":["Short stature and the effect of human growth hormone: Guidelines for the care of people with spina bifida"],"prefix":"10.1177","volume":"13","author":[{"given":"Joseph","family":"O\u2019Neil","sequence":"first","affiliation":[{"name":"Riley Hospital for Children, Section of Developmental Pediatrics, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Fuqua","sequence":"additional","affiliation":[{"name":"Riley Hospital for Children, Section of Pediatric Endocrinology, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/PRM-200710_ref1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1469-8749.1987.tb02140.x","article-title":"Growth of trunk and legs of children with myelomeningocele","volume":"29","author":"Duval-Beaup\u00e8re","year":"1987","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.3233\/PRM-200710_ref2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF00451900","article-title":"Growth and sexual development in children with meningomyelocele","volume":"144","author":"Greene","year":"1985","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.3233\/PRM-200710_ref3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/adc.77.1.32","article-title":"Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus","volume":"77","author":"L\u00f6pp\u00f6nen","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.3233\/PRM-200710_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050672"},{"issue":"6","key":"10.3233\/PRM-200710_ref5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s004310050851","article-title":"Arm span, serum IGF-1 and IGFBP-3 levels as screening parameters for the diagnosis of growth hormone deficiency in patients with myelomeningocele-preliminary data","volume":"157","author":"Trollmann","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.3233\/PRM-200710_ref6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1515\/jpem.1994.7.3.219","article-title":"Endocrine studies in children with myelomeningocele","volume":"7","author":"Perrone","year":"1994","journal-title":"J Pediatr Endocrinol"},{"issue":"1","key":"10.3233\/PRM-200710_ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yapd.2014.03.007","article-title":"Advances in the care of children with spina bifida","volume":"61","author":"Apkon","year":"2014","journal-title":"Adv Pediatr"},{"issue":"2","key":"10.3233\/PRM-200710_ref8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1515\/jpem.1999.12.2.153","article-title":"One-year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: A comparison of supine length and arm span","volume":"12","author":"Hochhaus","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"10.3233\/PRM-200710_ref9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/13638490500373465","article-title":"Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): The KIGS experience","volume":"9","author":"Trollmann","year":"2006","journal-title":"Pediatr Rehabil"},{"issue":"2","key":"10.3233\/PRM-200710_ref11","doi-asserted-by":"publisher","first-page":"100816","DOI":"10.1016\/j.dhjo.2019.06.005","article-title":"Scientific methodology of the development of the guidelines for the care of people with spina bifida: An initiative of the spina bifida association","volume":"13","author":"Dicianno","year":"2020","journal-title":"Disabil Health J"},{"issue":"2","key":"10.3233\/PRM-200710_ref13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1440-172X.2012.02017.x","article-title":"Nominal group technique: An effective method for obtaining group consensus","volume":"18","author":"Harvey","year":"2012","journal-title":"Int J Nurs Pract"},{"issue":"2","key":"10.3233\/PRM-200710_ref14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.semarthrit.2010.12.001","article-title":"Methods of formal consensus in classification\/diagnostic criteria and guideline development","volume":"41","author":"Nair","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.3233\/PRM-200710_ref16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2105\/ajph.62.3.337","article-title":"The nominal group as a research instrument for exploratory health studies","volume":"62","author":"Van de Ven","year":"1972","journal-title":"Am J Public Health"},{"key":"10.3233\/PRM-200710_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02072114"},{"issue":"1","key":"10.3233\/PRM-200710_ref19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EJE-16-0105","article-title":"Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: Study in patients with organic GHD","volume":"175","author":"Guzzetti","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.3233\/PRM-200710_ref20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.beem.2016.11.012","article-title":"Muscle and skeletal health in children and adolescents with GH deficiency","volume":"30","author":"Improda","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.3233\/PRM-200710_ref21","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1210\/jcem.81.8.8768878","article-title":"J clin endocrinol metab the effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency","volume":"81","author":"Saggese","year":"1996","journal-title":"Role of GH in the Attainment of Peak Bone Mass"},{"issue":"11","key":"10.3233\/PRM-200710_ref22","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: A two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.3233\/PRM-200710_ref23","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1359\/jbmr.070811","article-title":"Fracture incidence in GH-deficient patients on complete hormone replacement including GH","volume":"22","author":"Holmer","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.3233\/PRM-200710_ref24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","article-title":"Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: A prospective observational cohort study","volume":"3","author":"Mo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.3233\/PRM-200710_ref25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2265.2009.03686.x","article-title":"Childhood growth hormone deficiency, bone density, structures and fractures: Scrutinizing the evidence","volume":"72","author":"H\u00f6gler","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.3233\/PRM-200710_ref26","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1210\/jcem.87.8.8754","article-title":"Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency","volume":"87","author":"Baroncelli","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.3233\/PRM-200710_ref27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.bone.2007.06.028","article-title":"Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: A pQCT study of GH-deficient and small-for-gestational-age (SGA) children","volume":"41","author":"Schweizer","year":"2007","journal-title":"Bone"},{"issue":"3","key":"10.3233\/PRM-200710_ref28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1210\/jcem.86.3.7268","article-title":"Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents","volume":"86","author":"Lanes","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.3233\/PRM-200710_ref29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/pr.2017.271","article-title":"Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency","volume":"83","author":"Chen","year":"2018","journal-title":"Pediatr Res"},{"issue":"6","key":"10.3233\/PRM-200710_ref30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/cen.12393","article-title":"Cluster of cardiometabolic risk factors in children with GH deficiency: A prospective, case-control study","volume":"80","author":"Capalbo","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.3233\/PRM-200710_ref31","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/s0022-3476(96)70007-0","article-title":"Growth hormone treatment of children with myelomeningocele","volume":"128","author":"Rotenstein","year":"1996","journal-title":"J Pediatr"},{"issue":"2","key":"10.3233\/PRM-200710_ref32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/s0022-3476(96)70387-6","article-title":"Growth hormone treatment of children with neural tube defects: Results from 6 months to 6 years","volume":"128","author":"Rotenstein","year":"1996","journal-title":"J Pediatr"},{"issue":"9","key":"10.3233\/PRM-200710_ref33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1515\/jpem.2004.17.9.1195","article-title":"Treatment to near adult stature of patients with myelomeningocele with recombinant human growth hormone","volume":"17","author":"Rotenstein","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"10.3233\/PRM-200710_ref34","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1210\/jcem.85.8.6724","article-title":"Does growth hormone (GH) enhance growth in GH-deficient children with myelomeningocele","volume":"85","author":"Trollmann","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.3233\/PRM-200710_ref35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000121045","article-title":"Growth of growth hormone-treated and nontreated children before and after tethered spinal cord release","volume":"24","author":"Rotenstein","year":"1996","journal-title":"Pediatr Neurosurg"}],"container-title":["Journal of Pediatric Rehabilitation Medicine"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/PRM-200710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:36:50Z","timestamp":1777610210000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/PRM-200710"}},"subtitle":[],"editor":[{"given":"Timothy","family":"Brei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Heidi","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Jonathan","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":31,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/prm-200710","relation":{},"ISSN":["1875-8894","1874-5393"],"issn-type":[{"value":"1875-8894","type":"electronic"},{"value":"1874-5393","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,22]]}}}